Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

Clinical trial NCT00027300 · COMPLETED

Trial details

NCT number: NCT00027300
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2001-11-01
Primary completion: 2004-11-01
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.